Single-molecule biomarkers, such as CA 125 for ovarian cancer and PSA for prostate cancer, can be incorporated into routine blood tests through radioimmunoassay or similar traditional lab procedures, but these single-molecule biomarkers suffer from unsatisfactory sensitivity and/or specificity [33]. Here, KLK3 is linked to prostate carcinoma.